Stock Analysis
FALCO HOLDINGS (TSE:4671) Full Year 2024 Results
Key Financial Results
- Revenue: JP¥43.0b (down 8.3% from FY 2023).
- Net income: JP¥1.67b (down 26% from FY 2023).
- Profit margin: 3.9% (down from 4.8% in FY 2023). The decrease in margin was driven by lower revenue.
- EPS: JP¥152 (down from JP¥215 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
FALCO HOLDINGS Meets Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.
The company's share price is broadly unchanged from a week ago.
Balance Sheet Analysis
Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on FALCO HOLDINGS' balance sheet.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About TSE:4671
FALCO HOLDINGS
A medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan.